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THE test mice most commonly used for ascertaining the presence of the
mammary tumour agent are susceptible hybrid female mice obtained by mating
low-breast-cancer-strain females to high-breast-cancer-strain males. In these
test mice a low incidence of spontaneous mammary tumours was frequently
recorded (Bittner, 1939b; Murray and Little, 1939; Andervont, 1940; Gardner,
1941; Dmochowski, 1944a), and was frequently found to be higher than that of
their maternal parents (Andervont, 1945a). Of even greater interest was the
high tumour incidence reported in the progeny of susceptible low-cancer-strain
females mated to high-cancer-strain males which had been subjected to forced
breeding-that is, bearing a number of litters in quick succession (Andervont,
1945b). A similar high incidence of breast cancer was also observed in forcibly-
bred hybrid progeny of low-cancer-strain females of low susceptibility to breast
tumours mated to high-cancer-strain males (Bagg and Jacksen, 1937; Strong,
1943). Attempts to discover the mammary tumour agent in mammary tumours
of some of these hybrids proved unsuccessful (Andervont, 1945b). A number of
possibilities was suggested (Andervont and Dunn, 1949) to explain the appearance
of breast cancer in hybrid females: presence of a weak agent or small quantities
of it or even a different agent in low-cancer-strain female mice; transmission of
the agent from the male parent or influence of the more susceptible genetic con-
stitution of this parent; hormonal stimulation overcoming the absence or small
quantities ofthe agent; contamination; even de novo origin ofthe agent.
In connection with the initially recorded observations on tumours in hybrid
mice, an investigation was carried out in an attempt to obtain a high incidence
ofmammary tumours in hybrid mice bred in the laboratory, with a view to ascer-
taining the respective parts played by genetic constitution, hormonal stimulation,
and the agent in the development ofmammary cancer in these mice, obtained by
mating C57 Black low-cancer-strain females of low susceptibility to the agent to
RIII agent-harbouring high-cancer-strain males. It was also planned to study
the inheritance of mammary tumours in the progeny of these hybrid females
obtained by brother-to-sister matings.
Preliminary findings of this study have already been reported (Dmochowski,
1949a, 1949b, 1950a, 1950b, 1951a, 1951b). Biological tests for the presence of
the agent in some ofthese tumours as well as a study ofthe microscopical appear-
ance of breast cancer in these mice are now complete, and a full account of this
investigation is now possible. During the intervening years, since the presentL. DMOCHOWSKI
experiments were started, the problem of the origin of breast tumours in hybrid
mice ofvarious derivations has also engaged the attention ofseveral other investi-
gators (Foulds, 1947, 1949; Andervont and Dunn, 1948a, 1948b, 1949, 1950b;
Andervont,1950a; Bittner, 1952a; Muhlbock, 1952). Therefore, a comparison
ofthe observations in the present study with those of other investigators will also
be presented.
MATERIAL AND METHODS.
The experiments were started in October, 1947, by establishing a breeding
colony of thirty C57 Black low-cancer-strain females and ten RIII high-cancer-
strain males. The C57 Black strain mice originated from the Laboratories of the
Imperial Cancer Research Fund and have been under the writer's care since 1946.
Spontaneous mammary tumours have not been recorded in this strain since its
establishment in the Imperial Cancer Research Fund Laboratories in 1941. The
ancestors of the C57 Black strain females used in the experiments were all free
ofmammary tumours. A subline of C57 Black strain is now established in which
a number ofmammary tumours has been recorded by the author. This subline
comes from one of the original threelitters brought from the Laboratories of the
Imperial Cancer Research Fund. The progeny of these litters has been kept
separately, and no breast tumours have so far been recorded in the descendants
of the other two litters. The description of the subline in which tumours have
appeared will be the subject ofa separate communication. TheRIII strain mice
were also obtainedfrom the same source and maintained since 1946. The tumour
incidence of 83 per cent at an average age of8X5 months in breeding females
(Dmochowski and Gye, 1943) has with small variations remained approximately
the same. It was known that mice ofhigh-cancer strains derived from the fourth
or later litters develop a higher incidence of breast cancer than those from the
first two litters (Bittner, 1942), and that theappearance ofan active agent in mice
deprived of it by foster nursing had been recorded in the progeny obtained from
the third or later litters (Bittner, 1943). Hybrid progeny ofthe C57 Blackstrain
femaleswastherefore takenonlyfromthefourth orlaterlitters forthe experiment,
micefromearlierlittersbeing usedforvariousotherpurposes. The (C57 x RIII)Fl
hybrid females which were litter mates were divided into two groups. Only two
hybrid females were taken from each of the C57 females mated to RIII strain
males, if possible from the same or foliowing litters. Whenever two females
were not available from the same litter, the mice from later litters were included
in the control group. In this way two groups, each comprising thirty (C57 X
RIII)F1 hybrid females, were obtained. Mice of the control group were allowed
to breed in a normal way and mice of the experimental group were forcibly bred
byremoving theirlitters as soon astheywereborn. Mice ofone ofthe later litters
from fifteen hybrid females in this group and of one litter of a female from the
control group were saved for brother to sister matings. These mice in turn,
after saving one litter, were forcibly bred and this procedure was followed for
several generations. The progeny of six (C57 x RIII)F1 hybrid females, which
had been subjected to forced breeding, was maintained for six generations and
theprogenyofnineadditional(C57 x RIII)F1hybrids,treatedinasimilarmanner,
for onlythreegenerations. The descendants ofa (C57 x RIII)F1 hybrid female,
which had beennormallybred, were maintainedby normal breeding for five gene-
rations.
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In addition a number of litters from several C57 x RIII hybrid females was
secured after the development of a mammary tumour, in an attempt to ascertain
any difference in the tumour incidence and the presence of the agent in mice
born before and after their mothers developed a tumour. The progeny of mice
born before and after the development of breast cancer was also kept for obser-
vation of any difference in the incidence of mammary tumours.
Biological tests of twenty-three breast tumours which developed in (C57 x
RIII)F1 hybrid females and in their progeny were carried out for the presence of
the mammary tumour agent. The tumours, after securing a part for histological
examination, were frozen and desiccated as previously described (Dmochowski,
1946). After storage in the ice-chest for varying periods oftime according to the
availability of test mice, the desiccated tumour tissue was ground in a mortar
and resuspended in distilled water in a proportion of 1: 10, and then usually
further diluted to a volume according to the number of test mice available, so
as to give daily each animal 1 ml. of extract intraperitoneally. The number of
injections and the amount of material given at each injection varied according
to the total amount of tissue available. The intention always was to give as
much material as was available. (C57 x A)F1 hybrid females, 4 to 5 weeks old,
were used as test mice. All test mice were forcibly bred by removing the first
three litters within 24 hours of birth, and then allowed to breed in a normal way.
Spontaneous mammary tumours have not been observed in (C57 x A)F1 hybrid
females after similar treatment (Dmochowski, 1944b, 1945a), and the total tumour
incidence in all these mice, so far used, is below 3 per cent. The test mice as
well as all other mice were maintained under similar conditions on a diet of " rat-
cake" cubes, biscuits, and oats, and given an unlimited supply of tap-water.
Intermittent outbreaks of enteritis during the later part of the experiment were
successfully controlled by streptomycin supplied in a final concentration of 0-025
per cent in drinking water. The number of animals kept in one cage was six in
the case ofthe test mice, and from two to four in the case ofall other mice.
Histological examination of all tumours, whenever possible, was carried out.
Tumours which werenot examined microscopically were excluded from thepresent
study. The tissues were fixed in Bouin's fluid and stained with haematoxylin
and eosin.
RESULTS.
No mammary tumours were observed in any of the (C57 x RIII)F1 hybrid
females which had been bred in a normal way, although they lived to an average
age of approximately 19 months (Table I). One of the females developed a
TABLE I.-Tumour Incidence in Normally-Bred (C57 x RIII)F1 Hybrid Females.
Number Earliest Average
of mice tumour Mice developing tumours. Number age
alive at appearance Mice dying without tumours. 'Number of mice of mice
earliest in forcibly of dying dying
tumour bred Age in months. tumours. without without
appear- hybrids , tumours. tumours
ance. (days). 12. 14. 16. 17. 18. 19. 20. 22. 23. 26. (days).
0 0 0 0 0 0 0 0 0 0
29. 290 . ... 0 29 559
1 1 8 1 5 3 2 4 2 2
(372-794)
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tumour which on histological examination was found to be a lymphosarcoma.
The average number oflitters bom to these hybrid females was three, and varied
from two to seven. The number of breast tumours which developed in their
litter mate (C57 x RIII)F1 hybrid females, which had been forcibly bred, is
shown in Table II. The number oflitters born to these hybrids varied from four
to ten and the average number was 6-4. Among these hybrids, the tumorous
females had an average of 6*5 litters and the tumour-free females 6-4 litters.
There was no difference therefore in the number of litters born to these two
types of females which had been forcibly bred.
None of the C57 Black strain mothers, mated to RIIIstrain males and bred in
a normal way, developed mammary cancer, although they lived to an average
age of 19 mouths. Twelve C57 Black strain females, which were litter-mates
of some of the C57 females mated to RIII strain males, were forcibly bred with
their own litter-mate males, and none developed breast cancer, although they
had an average of 5*2 litters and lived to an average age of 18 months. At the
same time a number of other low-cancer-strain female mice, ten C strain, supplied
by Dr. H. B. Andervont, ten JK strain, supplied by Dr. L. C. Strong, eleven
P strain and five Y strain, supplied by Dr. C. C. Little, were also forcibly bred
with their own strain males. In none of these females was mammary cancer
observed. Their average life-span with the average number of litters born shown
in parentheses was: 19 months (7.4), 20 months (8.2), 18 months (5.4), and
17 months (5.6) respectively.
The appearance of mammary tumours in some of the (C57 x RIII)F1 hybrid
females following forced breeding could be explained by the transmission of small
amounts of the agent by their C57 Black strain mothers after mating to RIII
strain males, as originally suggested by Foulds (1949), although none of the C57
females developed breast cancer, and further by activation of the agent in their
susceptible hybrid progeny by increased hormonal stimulation. The observa-
tion that none of the C57 strain females developed mammary tumours after
mating to C57 strain males and forced breeding points against the possibility of
C57 Black strain females harbouring a weak or attenuated mammary tumour
agent. It is now well known that various sublines of C57 Black strain differ
considerably in their susceptibility to the agent. C57 strain mice of the subline
of the present experiments, when foster nursed by RIII strain females, developed
an incidence of mammary cancer of only 11 per cent (Dmochowski, 1948). This
low susceptibility was probably responsible for the failure to induce mammary
cancer in mature C57 mice of this subline even by a combined action of large
doses of material containing the agent and forced breeding (Dmochowski, 1948).
Again this low susceptibility may also have been responsible for C57 mice of this
subline remaining tumour-free after mating to RIII high-cancer-strain males as
well as for their hybrid progeny, bred in a normal way, not developing mammary
cancer. A further indication against the possibility of C57 Black mice of this
sublineharbouring a weak agent orin small quantitieswasprovided bythe absence
of the agent in mammary tumours induced in both virgin and breeding C57
females by treatment with methyloholanthrene (Dmochowski and Orr, 1949). At
least it can be stated that even treatment with methylcholanthrene combined
with breeding failed to reveal either a weak agent or a strong agent on a genetic
background of low susceptibility in C57 Black mice of the subline used in the
present study.
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In an attempt to increase, if possible, the mammary tumour incidence in the
descendants of (C57 x RIIJ)F1 hybrid females, the progeny of these mice was
continued for several generations by brother to sister matings and subjected to
having as many litters as possible, after saving at least one litter for the next
generation. The progeny oftwo (C57 x RIIIF)1 hybrid females which developed
mammary cancer is shown in Fig. 1 and 2. The forcibly-bred progeny of four
(C57 x RHIJ)F1 hybrid females which had died free from tumours, also continued
for six generations, is presented in Fig. 3 to 6. In these figures, the number of
mammary tumours which appeared in each successive generation of both the
tumorous and non-tumorous hybrids may be seen at a glance as well as the con-
secutive number oflittertowhich the micewith tumours belonged,theageatwhich
they developed cancer or died without showing a tumour. It will also be noted
that as a rule the hybrid females of the first three generations belonged to later
litters than those of the following generations. This was done in an attempt to
increase the activity ofthe mammary tumour agent, should one be present in the
hybrid females. It may also be seen in Fig. 3 to 6 that descendants of tumorous
females can remain tumour-free for two, three or four successive generations
before developing mammary cancer, and that descendants of a non-tumorous
female, in spite of reaching tumour age, may show no mammary tumours for as
many as five generations before developing breast cancer, in spite of inbreeding
and intensive hormonal stimulation. It may be of interest to point out that
Andervont (1949a, 1949b) found the agent to be transmitted through three or
four successive generations of susceptible mice without inducing mammary
cancer. Further, the study of the distribution of mammary tumours in charts
of the progeny of tumorous and non-tumorous hybrids, shown in Fig. 1 to 6,
indicates the possibility of the agent being involved in the development of these
tumours.
A comparison ofthe age ofthe earliest tumour appearance, tumour incidence,
average tumour age and average age at death of the progeny of individual tumo-
rous and four tumour-free (C57 x RII1)F1 hybrid females is shown in Table III.
As can be seen, there was little, if any, difference between the forcibly-bred pro-
geny of the two (C57 x RIII)F1 females which developed breast cancer and the
forcibly-bred progeny of the four (C57 x RIII)F1 hybrid females which died
without tumours. Table IV demonstrates the tumour incidence and tumour
age in the forcibly-bred progeny of additional nine non-tumorous (C57 x RII1)F1
females which was continued for three generations. The tumour incidence,
although varied in the progeny of the individual hybrids, was lower and the age
ofbreast tumour appearance higher than thosein theprogeny ofthetwotumorous
and also of the four tumour-free (C57 x R111)F1 hybrid females. The progeny
of these nine non-tumorous hybrids showed considerable variations in tumour
incidence and tumour age; the descendants of two hybrids (No. 27 and 36)
showed no tumours in the three generations observed; those offour other hybrids
(No. 31, 33, 21 and 72) did not develop tumours until the third generation of
inbreeding; the progeny ofonly one hybrid female (No. 40) developed mammary
cancer in the second generation, although all of them had been subjected to con-
siderable hormonal stimulation. In Table V is shown the tumour incidence, the
age of appearance of the earliest tumour and the average tumour age in the six
generations of the forcibly-bred progeny of the two cancerous (C57 x R111)F,
hybrid females. It can be seen that the tumour incidence in all six generations
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was high, with only slight variations from 67 to 88 per cent. Similarlythe average
tumour ageshowedcomparatively small changes andwas quitelow. Themajority
of tumours in each generation developed during the first 12 months. The age of
appearance of the earliest tumour showed gradual decrease from 284 days in the
second to 125 days in the seventh generation. In Table VI is presented the age
F6
(X)44 N 378
(V)38 N 185
(V)37 r 374
T 249 J (IV)35 T 271
(IV)34 T 235
T 296 (IV)32 T 216
(1)30 T 251
N 491 (1)29 T 279
(1)46 T 455 (111)97 N 148 J (IX)43 N 265
(IIX)44 T I81
(111)96 T 265 (1)27 T 255
1(111)10 T 284 r(X)20 T 246 (1)50 T 498 F(1)44 N 232 (1)26 T 269
/ l (11)48 T 249 (1)43
I(X)19 T 323 (V)47 T 248 (1)58
T 502-\
(1)57
"1li1 T 285 (X)17 N 396 (1)4 N 619 \ (1)6
(X)15 T 276- (111)45 T 316 (111)90
T 472 (1)62 T 275
T 239 \ (1)61 T 407
T 403 - (111)36 T 295
(111)35 T 192
I T 326 (1)83 T 125
N 517 - (1)18 T 455
T 348 (1)17 N 232
-(VlI)87 T 289
T 441 (V11)86 T 334
T 260 X---- (1)86 T 258
(1)85 T 258
(111)89 T 373 - - (11)77 T 242 (1)9 T 365
\\ (1)8 T 396
\(11)76 T 423--- \ (1)6 T 197
\( (1)5 T 240
FIG. I.-Chart of forcibly-bred progeny of tumorous (C57 x RIII) F1 No. 69 female.
Roman numbers in parentheses = consecutive number of litter; T = tumour; N = died;
L = alive. Number preceding letters T, N or L = number of female; number following
letters T, N or L = tumour age or life span in days.
of the earliest tumour appearance, the appearance of mammary tumours accord-
ing to months, the tumour incidence, and the average tumour age in six genera-
tions of combined forcibly-bred progeny of the thirteen non-tumorous (C57 x
RIII)F1 hybrid females. The tumour incidence increased from 19 per cent in
the second to nearly 60 per cent in the fifth and later generations. The average
tumour age showed a gradual decrease from 16 to 11 months in the seventh
generation, and similarly the age of appearance of the earliest mammary tumour
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decreased gradually from 10 months in the second to 5 months in the last genera-
tion. The distribution ofbreast tumours in the normally-bred progeny of(C57 X
RIII)F1 No. 22 female which had also been bred in a normal way is shown in
Fig. 7. Again the number of breast tumours which appeared in each successive
Fl F2 F3 F4 F 5 F6 F7
(V)52
(V)49
(V)48
(V)46
(IX)77 N 574 (11)23
34 T 483-- (VI)30 N 560 (11)22
(IX)76 T 280 (1)10
(1)9
-r (1)58 L 351
(1)64 T 371 (1)59 L 351
(1)29 N 393
(1)63 T 371 (1)28 T 365
(1)64 T 196
(1)46 T 363 (IV)76 L427 (1)65 T 275
(IV)77 L 427 (1)52 N 234
(1)49 T 481 (11)71 T 329 (1)53 T 203
T 299J (1)48 T 393 (11)70 N 403
J (1)61 T 292
T 403 (1)44 T 238- (1)60 L 548
f (IV)80 N 340
T 262 (1)43 T 340 )-(IV)79 T 322
r(1)SS T 305
(1)54 L 548 (1)26 T 377
T 226 < (1)41 T 265 (1)58 L 544 / (1)25 T 336
(1)40 T 338 (1)57 T 429 (11)83 T 351
(1)24 T 237 (11)82 T 303
T 459 (1)30 T 203 1 (1)23 T 299 - (11)62 T 322
-7 I (11)60 T 264
(1)29 T 272- (1)21 T 279 (11)59 T 307
(1)20 T 334 (1)56 T 266
-(11)27 N 479 (1)18 T 406 (1)54 T 455
T 465 (11)26 T 229 - (1)17 N 438 (1)53 T 427
(1)15 N 237 \ (11)20 T 257
T 294 (11)90 T 310 (1)14 N 241 \\ (11)19 T 239
(11)5 T 326
(11)4 T 309
(1)92 T 368
(1)91 T 383
(11)91 T 258 (11)6 T 291 - (1)30 N 478
N 293 (11)24 N 583 (1)5 T 226 (1)29 T 256
(11)23 T 455 ''(11)5 T 268
(11)50 T 268
FIG. 2.-Chart offorcibly-bred progeny of tumorous (C57 x RIII)F1 No. 34 female.
Roman numbers in parentheses = consecutive number of litter; T = tumour; N = died;
L = alive. Number preceding letters T, N or L = number of female; number following
letters T, N or L = tumour age or life span in days.L. DMOCHOWSKI
generation ofthe progeny ofthis non-cancerous hybrid female may be seen in this
figure as well as the consecutive number oflitter to which the mice belonged which
developed tumours. It would have been of interest to obtain the first litter of
this female and its progeny and compare any mammary tumour incidence in this
progeny with that of the progeny obtained from the sixth litter, but this could
not be done owing to limitation of space. Table VII shows the age of earliest
tumour appearance, the tumour incidence, and the average tumour age in the
normally-bred progeny of this non-tumorous (C57 x RIII)F1 hybrid female. As
can be seen, the age of the earliest tumour appearance decreased gradually from
1I to 4 months in the sixth generation of inbreeding; mice of each generation,
FI F2 F3 F4 F5 F6 F7
(111)99 N 489 - (1)90 N 353 (1)14 T 298
(111)98 N 394 - (1)87 T 348 (1)88 N 175
f (i)67 T 456
(1)97 T 558. /-(III 63 1, 697 (1)66 L 586
(1)96 N 451 (1)34 N 660 (111)62 L 697 - (1)96 N IS0
(1)95 L 574
(VII)69 T 403 (1)33 N 695 (11)49 N 573 - (1)7 L 632
(11)48 N 643 '(1,61 N 508
(1)60 L 598
21 N 748 (V)12 N 900
(11)88 T S61 (11)68 L 696- (1)3 L 583
(VII)68 N 164 / (1)2 L 583
(1)94 N 5S6 (11)87 T 505 -Q(I)10 N 756 (11)52 N 471
(11)51 L 598
(1)93 T 216 (11)85 T 320 (1)6 T 303 (1)76 T 285
I (1)75 T 266
(11)84 T 304 (1)4 T 342 (1)27 T 269
(1)26 T 372
\(1)3 T 316 (111)33 T 258
\:(111)32 T 203
FIG. 3.-Chart of forcibly-bred progeny of non-tumorous (C57 x RIII)F, No. 21 female.
Roman numbers in parentheses = consecutive number oflitter; T = tumour; N = died;
L = alive. Number preceding letters T, N or L = number of female; number following
letters T, N or L = tumour age or life span in days.
except the second, developed a high incidence of breast cancer, and the average
tumour age decreased from 16 to 11 months in the last generation.
A comparison of the mammary tumour incidence in the progeny of (C57 X
RIII)F1 hybrid females which died free of cancer and in the progeny of (C57 x
RIII)F1 hybrids which developed breast cancer is shown in Table VIII. The
breast tumour incidence in the forcibly-bred progeny ofthe non-cancerous (C57 x
RIII)F1 hybrid females was lower and the average tumour age considerably
higher than those in the forcibly-bred progeny ofcancerous (C57 x RIII)F1 hybrid
females, but this difference in tumour incidence and average tumour age gradually
became smaller in successive generations of the progeny. The difference in the
age of the earliest tumour appearance in the descendants of these two types of
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F4 F5 f6
(1)24 N 362
(1)23 N 337
(11)35 T 375
(11)34 N 375
(11)27 N 89 (1)73 T 471
(1)72 T 371
(11)26 N 307 ,/ (1)70 L 658
(1)69 N 527
F(X)49
(X)47
68 N 376-(VI()22 T 308
(IX)23
(IX)21
[(1)82
(1)81
! T 322-J (1)I N 312J/ (1)86 N 428
(1)99 T 271f' (1)85 T 254
N 380 (11)85 T 243 l (1)12 T 272
(11)84 N 362 -1--(I)IIT1 556
j (111)23 T 335
T 323 r(V)41 T 270 (111)22 L 468
/(V)40 T 347-1(180 T 329
(1)9 T 391 (II11)79 T 302 (1)81 T 287
(1)8 T 411 (1)84 T 246
I (1)60 T 295 (1)83 T 244
T 300 (1)80 T 271 (11)18 T 264
(111)73 T 225 (1)59 T 360 (11)17 T 143
(11)57 T 252 - (1)80 T (89 (11)70 N 568 (111)72 N 622 (11)56 T 441 (1)15 T 294
r (1)67 T 182
T 360 (11)69 N 478 (11)70 N 514 (1)88 T 256 (1)66 T 231
(1)98 T 201
(11)69 N 508 a (1)87 T 246--- (1)97 N 204
(1)64 T 203
(1)84 T i86 ( (V)47 T 273
(V)46 T 182
(11)79 T 331__ (()98 T 234
T 329 (11)52 T 373 (1)68 N 415 (11)78 T 415 (1)97 T 231
(V)94 N 439 (11)10 T 192
(VI)8 N 133 (1)8 T 345 ( 5I)S T 272 / (11)9 N 323
,-(11)99 T 268
(1)37 N 681 (11)66 N 354 /-(11)98 T 279
/ (121 T 347
T 265 (VI)7 T 287 (i)36 T 249 (11)65 T 184- (1)20 329
(IV)5 T 328
(VI)6 N 286 (1)24 T 506 (1)25 N 215 / (IV)4 T 297
V()30 T 319
(1)23 T 364- (1)29 T 32i (V)29 N 200
(1X129 T 450 11)22 N 259 (1)28 N 447 (IV)7 T 200
(11)33 T 304 (1)27 N 116 (1)65 N 372
\ (1)26 N 419 (V)47 L 375
IIX)28 T 303 (11)32 N 275 (1)46 L 591 1V)46 L 375
(1(33 T 247 (111)8 T 280
(11)36 T 401 L (111)7 T 280
(11 35 (1)75 T 221
11)35 T (((32 N 370 (1)74 T 210
(1)72 T 427
(11)30 r 290 (1)71 T 341
(11)29 r 235 (1(69 547
(1(68 T 261
(VII)82 L 375 (V)49 T 257
(V)50 T -197
FIG. 4.-Chart of forcibly-bred progeny of non-tumorous (C57 x RIII)F1 No. 68 female.
Roman numbers in parentheses = consecutive number oflitter; T = tumour; N = died;
L = alive. Number preceding letters T, N or L - number of female: number following letters T, N or L = tumour age or life span in days.
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TABLE VIII.-Comparison of Tumour Incidence in Progeny of Tumorous and
Non-Tumorous (C57 x RIII)F1 Hybrid Females.
Tumorous females. Non-tumorous females.
Forcibly bred progeny.* Fril Forcibly bred progeny.t Normally bredprogeny.:
Genera- Earliest
tion. tuorletu Average Earliest ge tumour tumour Tiimourtumour Tumour Aver EamorlieTumu
apper- ncidncetumour tumour T umourAvrg appear- incidence ageour appear- incidence age appear- incidence tumgeur
(nco/ (d)s. ance (%. (age) ance (oM. (days). (days). (days). (days). (days).
F2 . 284 67 285 . 308 19 467 . 0
F3 . 246 67 281 . 265 26 390 . 321 100 481
F4 . 226 85 338 . 187 39 393 . 424 60 454
F5 . 203 81 349 . 165 60 372 . 381 46 420
F6 . 223 68 329 . 184 49 325 . 121 46 325
F7 . 125 84 292 . 143 55 318
* Progeny of 2 females.
t Progeny of 13 females (of 9 females continued for 3 generations only, and of the remaining
females for six generations).
t Progeny of 1 female.
hybrid females was less apparent, and in the later generations of the progeny
of non-tumorous hybrid females it was even lower than that in the progeny of
tumorous (C57 x RIII)F1 hybrids. It may be of interest to point out that
Foulds (1949) recorded a very low breast tumour incidence (1 to 3 per cent) at a
late age (16 months) in forcibly-bred progeny of a non-tumorous (C57 x RIII)F1
hybrid compared with a high (70 per cent) at 11 months in the progeny of three
tumorous (C57 x RIII)F1 hybrid females. The age of the earliest tumour
appearance and the average tumour age in the progeny bred in a normal way of
one cancer-free (C57 x RIII)F1 hybrid female was distinctly higher than those
in the forcibly-bred progeny of both tumorous and tumour-free (C57 x RIII)F1
hybrids. The tumour incidence in the normally-bred progeny was, with one
exception, lower than that in the forcibly-bred progeny of tumorous hybrid
females and, again with one exception, approximated to that in the forcibly-bred
progenyofnon-tumorous hybridfemales. It shouldbepointed outthat theresults
ofthe comparison ofthe behaviour ofnormally-bred progeny ofone non-tumorous
female with that of the forcibly-bred progeny of thirteen non-tumorous hybrid
females may not be the same as those which would have been obtained should
this comparison have been extended to similarly maintained progeny of a number
of other cancer-free hybrids which had been bred in a normal way. This point
may be seen from the observations on the forcibly-bred progeny of four non-
tumorous (C57 x RII1)F1 hybrids compared with those on similarly treated
progeny of two tumorous (C57 x RIII)F1 hybrid females. The difference in
mammary tumour incidence and average tumour age between these two groups
of hybrid females became pronounced only after including the observations on
the progeny ofnine additional non-tumorous (C57 x RIII)F1 hybrid females. It
is therefore possible that the results of the comparison ofnormally with forcibly-
bred progeny of non-cancerous hybrids would have been different as in the case
ofthe comparison offorcibly-bred progeny ofnon-tumorous with that oftumorous
hybrids. It is not known whether the results of Foulds' (1949) comparison of
forcibly-bred progeny from tumorous and non-tumorous hybrid females would
89L. DMOCHOWSKI
F2 F3
(11)40
f(VI)12 N 709 (11)39
(IV)33 T 505 (11)43
(VI)II N 477 1 (11)42
38 N 643
(VI)8 N 702 (111)37
(IV)32 N 520 (VII)36
(VI)7 N 461
(1)9
(1)18
F4 F5 F6 F7
(1)50 N 506 -(111)15 T 295
(111)13 L 677
(1)40 T 567 (1)49 N 506 (111)12 L 677
(VI)24 T 284
r (1)47 N 432 (VI)23 T 260
1(/ /' r(111)10 T 261
N 643 (1)39 N 557 (1)46 T 364 (111)9 T 244
(11)58 T 319
(11)46 N 438 (11)57 T 246
/ _ ~~~~~~(11)55 T 312
(11)93 T 317 (11)45 T 276 (11)54 T 304
/ (11)5 T 261
(11)40 T 291 + (11)4 T 275
11(VIII)41 T 300
/ (VIII)40 T 398
T 312 (11)92 T 374 (1)63 N 495 (11)93 N 408
(1)62 N 495 (11)49 N 372
/ (11)48 N 360
(1)61 N 495 (11)46 N 517
(1)59 N 676 (11)45 N 200
T 357 y-(11)55 N 583 / (11)43 N 229
\-(11)54 N 583 / (1)58 N 649 (11)41 N 448
(11)40 N 449
(1)18 T 483 -- (11)44 T 345
T 383 (111)87 T 529 (1)17 T 538 >- (11)43 N 162
(111)32 T 526
(111)86 N 601 (1)38 T 621 1 ()2 T 409
(1)1 T 409
(111)85 T 573 -(111)35 L 601 (1)77 T 499
(1)89 L 509
r (1)44 N 132 (1)88 T 266
/ r~~~~~~~(1)95 T 235
N 567 (VII)38 T 265 Z (1)43 T 514 . (1)94 T 217
(VI)68 L 530 (11)62 L 353
(IV)37 T 290 (VI)67 L 530 (41)61 L 353
(1)32 L 457
\ (VI)66 N 485 a (1)31 L 457
(1134 L 453
T 187 (1V)36 N 432 (11)74 L 671
\11 (1)35 L 453
(11)73 r 477 (1)78 N 407
(1)52 N 462 (11)71 N 604 (1)77 N 444
(11)70 N 603 (1)74 N 397
(1)51 T 426 (1)56 N 523 (1)70 N 556
(1)55 N 124 (1)69 T 533
(1)72 N 429
N 509 (1)54 r 392 (1)38 N 495
(1)52 T 383. (1)37 N 490
(I)S9 T 581
I N 564 (1)5I N 367 (1)58 T 510
(I)S0 T 190 (1)55 T 490
(1)53 T 324
(1)52 T 206
(1)S N 233
(1)49 N 275
(1P3 T 320
(1)92 T 232
FIG. 5.-Chart of forcibly-bred progeny of non-tumorous (C57 x RIII)F1 No. 38 female.
Roman numbers in parentheses = consecutive number of litter; T = tumour; N = died;
L = alive. Number preceding letters T, N or L = number of female; number following
letters T, N or L = tumour age or life span in days.
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F F2 F3 F4 FS F6 F7
J (1)1 T 417 (1)21 N 339
(1) II T 287 (IX)74 N 407
(IX)73 T 290 (1)13 T 417
(1)97 N 253 (I)1I L 484
(1)37 T 306 (1)10 T 329 (IV)49 N 133 (I)10 N 365
(IV)48 N 335 (1)24 N 327
(VII)56 T 260
(X)56 T 380 (1)36 N 223 - (1)13 T 165 (1)3 N 452 (91I)55 L 385
(1)95 T 275 (1)91 N 498
/ W (1)90 N 497
(1)8 T 423 (1)94 T 383 (1)19 T 379
/..L.~.... 38\--(1)I8 T 401
/(11)12 T 255-\ (1)27 T 512
\ (1)26 T 337
(VI)28 N 719 (X)55 T 320 - (1)34 T 480 (1)7 T 396 (11)1I T 25S- (1)41 N 463
(111)9 T 321- (1)38 T 441
(1)33 T 327 - (I)S T 330 (111)8 T 245 (111)2 T 364
(1)4 N 429- (1)92 N 273 (111)1 T 291
20 N 573
(IV)2 L 695
(VI)26 T 554 (VIII)5 N 480- (11)12 N 300 (1)10 N 630 (1)0 N 550 (IV)I T 640
(11)90 N S10
(1)36 N 4 (11)89 N 509
/ r~~~~~~/(1)47 N 342
1V111)4 N 547 (V)II N 555 (11)40 N 368 (1)35 N 572 (1)46 N 549
(11)64 L 581
(11)54 N 5S4 (11)63 N 530
(V)I0 T 421 (11)39 N 144 (11)53 N 316 - (1)13 L 632
(1)12 N 539
(1)41 T 343
(1)77 T 469 - (11)5 T 268 (1)40 N 487
| (11)4 T 275 (1)21 T 426
(1)76 T 299 (111)35 N 523 (1)20 T 347
\~~~~~~\ (1)78 T 364
(IX)S2 L 549- (111)37 T 264
(IX)SI T 363 (1)17 T 399
(1)16 T 399
FIG. 6.-Chart of forcibly-bred progeny of non-tumorous (C57 x RIII) F:1 No. 20 female.
Roman numbers in parentheses = consecutive number oflitter; T = tumour; N = died;
L = alive. Number preceding letters T, N or L = number of female; number following
letters T, N or L = tumour age or life span in days.92 L. DMOCHOWSKI
not have been different had the progeny of a greater number of non-tumorous
hybrid females been included in his study.
From the study of the distribution of cancerous females in the forcibly-bred
progeny of tumorous and tumour-free (C57 x RIII)F1 hybrid females and in the
normally-bred progeny of a cancer-free hybrid, shown in Fig. 1 to 7 and in Table
Fl F2 F3 F4 FS F6
(11)6 N 267
(IV)3 N 467
(1)6 N 443 (V11)4 L 446
(111)15 T 357
tl)4 T 411 / (111)16 T 357
(11)12 T 425 r(VI)35 N 349
(IV)4 N 261 //t(VI)36 T 312
(IV)3 N 188 (11)11 T 442 (11)13 T 281
T r(1)1I N 459
r (1)1 T 523 5(IV)7 N 387 F5(1)9 N 579 (11)8 T 339
(1)2 T 448 (IV)6 N 457 (1)8 T 454 (11)9 L 575
(1)3 T 630 - (1)1
(1)4 T 321
22 N 695 (VI)I N 447
(111)9
(111)11
(111)11
L (11)1 T 360
T 408 (VI)33 T 388
(11)22 T 423
T 381 L (11)21 T 361
T 440 - (1)41 L 347
(1)42 L 347
(1)43 T 121
1)18 N 370
I N 400 / (11)19 T 332
L (1)38 L 362
N 442 (J)39 L 362
N 220 - (1)30 T 374
(1)31 T 284
N 581 y(I11)24 T 318
N 622 - (111)25 N 512
(V)27 L 501
(V)28 L 501
FIG. 7.-Chart of normally-bred progeny of non-tumorous (C57 x RIII)Fj No. 22 female.
Roman numbers in parentheses = consecutive number of litter; T = tumour; N = died;
L = alive. Number preceding letters T, N or L = number of female; number following
letters T, N or L = tumour age or life span in days.
IV, conclusions may be drawn about the parent-offspring correlation and the
presence of the mammary tumour agent in these lines, especially in females with
tumours. Although, perhaps at first sight, the mammary tumours may appear
scattered throughout the pedigree-charts of some lines, yet even then in certain
lines there appears to take place a segregation of high-cancer lines. DetailedDEVELOPMENT OF MAMMARY TUMOURS IN HYBRID MICE
analysis revealed a more positive parent-offspring correlation. In the progeny
of the two (C57 x RIII)1F1 hybrid females with tumours, there were among the
descendants of tumour-bearing mothers 82 daughters with tumours and 22 with-
out mammary tumours, and among the progeny ofmothers without breast cancer
there were 23 daughters with tumours and 4 without breast tumours. In the
forcibly-bred progeny of the thirteen cancer-free (C57 x RIII)F1 hybrid females
the tumorous mothers had 134 daughters which developed breast cancer and 67
which died cancer-free, and the non-tumorous mothers had 81 cancerous and 165
non-cancerous daughters. In the normally-bred progeny of one cancer-free
(C57 x RIII)F1 hybrid the segregation was not so evident: mothers with breast
cancer had 16 tumorous and 12 non-tumorous daughters, and cancer-free mothers
gave birth to 12 cancerous and 12 non-cancerous daughters. Thus in the majority
of lines the chance that a female would develop mammary cancer was greater if
her mother had a tumour than if her mother died without a breast tumour. In
the progeny of the two (C57 x RIII)F1 tumorous females even the progeny of
tumour-free mothers showed a greater tendency towards tumour development
than theprogeny oftumour-free mothers derivedfromthethirteen (C57 x RIII)F1
non-tumorous hybrid females. Therefore, there was a strong indication of the
presence of the agent in these hybrids and of its transmission to their progeny
which developed mammary cancer either after inbreeding alone or following
inbreeding combined with intensive hormonal stimulation.
A search for the possible influence of age on the development of mammary
tumours in the hybrid progeny (Tables I, II, V, VI and VII) showed that in all
lines the age of tumour-bearing females was distinctly lower than that oftumour-
free mice. Thus in the progeny ofthe two (C57 x RIII)F1 females with tumours,
the tumour-bearing mice lived to an average age of 11 months before the develop-
ment of breast cancer and the tumour-free mice to an average age of 14 months.
In the descendants of the thirteen non-tumorous hybrid females, the average age
ofmice with cancer was 13 months and ofmice without breast tumours 17 months.
The average tumour age ofmice in the progeny ofa non-tumorous (C57 x RIII)F1
female, which had been bred in a normal way, was 14 months, and the average
life-span of mice without breast cancer was 16 months. Thus the age, as such,
had no influence on the development of breast cancer in these hybrid females.
As can be seen in Tables IX and X, the study of a possible influence of the
number of litters born to each female on the development of breast cancer in the
hybrid mice revealed that among the descendants of the two tumorous (057 x
RIII)F1 hybrid females, the tumour-bearing mice had an average of 6-2 (from 1
to 13) litters and the tumour-free mice an average of 6-7 (2 to 13) litters. Among
the forcibly-bred progeny of the four tumour-free (C57 x RIII)F1 hybrids, tumo-
rous mice had an average of 7 3 (1 to 13) and the mice without tumours an average
of 8-3 (1 to 16) litters. A greater number of litters was therefore required before
mice developed breast cancer in the progeny of tumour-free (C57 x RIII)F1
hybrids than that required in the descendants of tumorous (C57 x RIII)F1 before
they showed breast cancer. This difference is even more pronounced in the
progeny of nine tumour-free (C57 x RIII)F1 hybrid females, in which mice with
breast tumours had an average of 9-2 (5 to 13) litters and tumour-free mice an
average of 9-5 (2 to 16) litters. In the combined descendants of the thirteen
tumour-free (C57 x RIII)F1 hybrids, the average number of-litters for tumorous
mice was 7.4 (1 to 13) and for tumour-free mice 8 7 (1 to 16) litters. Cancerous
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TABLE IX.-Number ofLitters Born in the Progeny of Tumorous (C57 x RIII)F1
Hybrid Femnales Before either Tumour Appearance or Death.
Number
No. oflitter. of mice Number Genera- alive at of mice
tion. earliest alive. __________________________ _ + tumour
0. 1. 2. 3. .4. 5. 6. 7. 8. 9. 10. 11. 12. 13. appearance.
2
1 ... 2
0
1 0 1
2... 3
0 1 0
- 1 1 1 0 0 1
3... 6
0 O 0 1 1 0
1 1 3 2 1 1 1 1
4 . - - - - - - . 13
0 1 0 1 0 0 0 0
1 1 2 2 4 2 3 1 4 1 0
5. ...- - - - - - - - _ _. 26
1 0 2 0 0 0 0 1 0 0 1
2 1 0 2 5 3 4 4 2 2 1
6. - - - - - - - - - - - - - 38 . o
0 0 1 0 1 1 1 1 2 0 0
7 4 4 5 6 6 7 4 1 1 1
7 .- - - - - - - - - - - - 55 . 2
1 1 0 1 0 1 0 2 0 0
Numerators Number of mice developing tumours.
Denominators Number of mice dying without tumours.
mice in the progeny of the one (C57 x RIII)F1 non-tumorous hybrid which had
been bred in a normal way had an average of 6-2 (2 to 10) and non-cancerous
mice an average of 6-1 (2 to 12) litters. Thus the mice which developed breast
cancer in each of the lines did not have more litters than the mice which died
without developing a tumour, but the progeny of the thirteen non-tumorous
hybrid females had a greater number of litters before the appearance of a
mammary tumour than the progeny of the two tumorous hybrids.
A connection between inbreeding and probably hormonal stimulation and the
appearance of breast cancer in the progeny of these hybrids was found after an
assessment ofthe number oflitters born to females before they developed cancer.
As can be seen in Tables IX and X, in mice ofeach generation ofprogeny ofboth
cancerous and non-cancerous (C57 x RI1I)F1 hybrids, the number of females
which had only five litters before developing a tumour increased in each successive
generation, although in all generations the majority offemales had more than five
litters before the appearance ofbreast cancer. As shownin Table XI,the number
oftumour-bearing females born in the first litter also increased in each successive
generation, in spite of the increasing number of tumorous females born in later
litters. Further, an increase in the amount of the tumour agent as a result of
securing later litters for obtaining progeny for each successive generation and itsDEVELOPMENT OF MAMMARY TUMOURS IN HYBRID MICE
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activation by inbreeding and intensive hormonal stimulation (forced breeding)
must also be taken into consideration as a possible cause ofthe increasing number
of tumorous females born in the first litter in each successive generation.
Foulds (1947, 1949) reported an incidence of 15 per cent ofmammary tumours
at an average age of 10 months in forcibly-bred hybrids of similar derivation.
This compares with an incidence of 14 per cent at 13-3 months in (C57 x RIII)F1
hybrids of the present study. Foulds (1949) noted that the distribution of mam-
mary tumours in the hybrid progeny of C57 Black strain mothers suggested a
strong familial factor, the tumours appearing mostly in litters of certain C57
females. This limitation oftumorous hybrid females to certain C57 strain mothers
could not be detected in the present study, because although only four hybrid
females developed breast cancer, the majority of (C57 x RIII)F1 hybrids trans-
mitted the tendency to tumour development. Therefore, the progeny not only
oftumorous but also the progeny ofthe majority ofnon-tumorous (C57 x RIII)F1
hybrids, in spite of individual variations, developed a high incidence of breast
cancer. It appears also that the majority of non-tumorous hybrid females trans-
mitted the mammary tumour agent to their progeny, thus showing no limitation
to certain C57 Black strain mothers. It isprobable that themajority ofmammary
tumours are similar to those which developed in the minority of hybrid females
or their back-cross progeny in the experiments of Andervont and Dunn (1948a,
1948b, 1949, 1950b). While the tendency to mammary tumour development in
the hybrid progeny of susceptible low-cancer-strain females was not limited to
certain ofthesefemales inthestudiesofAndervont and Dunn (1950b), thetendency
to the transmission of the mammary tumour agent was limited to the hybrid
progeny of a few females. Thus, the tendency to breast tumour development
and/or to transmission of the agent may vary in the hybrid progeny according
to the origin of their low-cancer-strain mothers and probably also male parents,
and they may also vary in the hybrid progeny of low-cancer-strain mothers from
different sublines ofthe samestrain. Foulds (1949) reported datawhichsuggested
the presence and transmission of the agent in hybrids of similar derivation to
that of hybrids in the present study, but pointed out that his (C57 x RIII)F1
hybrid females were not bred for determination of mammary tumour incidence.
Observations on hybrids ofthe present experiments strongly indicate the presence
and transmission of the agent by at least the majority of hybrid females.
In addition, the incidence of mammary tumours was examined in litters of
several hybrid females before and after they had developed tumours. This was
done in an attempt at ascertaining any possible increase in the tumour incidence
and in the amount of the agent after tumour development (Table XII). In a
case of two hybrid females, there was no difference in the number of tumours in
mice of litters and several generations of their progeny before and after the
development ofbreast cancer in their hybrid mothers, both types of litters show-
ing a high incidence of mammary tumours. In a case of two other females there
were no tumours in litters before they had developed mammary cancer but
tumours appeared inlitters obtained afterthesefemaleshad shown breast tumours,
and this may indicate an increase in the amount ofthe agent present or its appear-
ance only after the development of a mammary tumour in these hybrid females.
The number of tumours increased in the litter of one female obtained after she
had developed mammary cancer, and in the case of another hybrid female a
tumour developed in a littler obtained before but no tumours in litters secured
7
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TABLE XII.-Tumour Incidence in Litters Born Before and After the Appearance
of a Tumour.
Before tumour development. After tumour development.
, ~~~~~~~~~~~A,
Number
of mice Genera- alive
to. alive at t earliest
tumour
appear-
ance.
F3
F4
F5
F6
F7
2
4
11
16
26
(Conse-
secutive
no. of
litter)
Number
of
tumours.
(IX)
2
4
7
8
20
No. 22. F2 T (308).*
(VI)
1
4
3
No. 21. F3 T (265).*
287
366
262
470
364
2
3
7
F7 . 11 9 284 262 . 13
(IX)
2 377
3 346
3 257 395
(2L)
9 275 372
(3L)
No. 37. F5 T (290).*
(II)
1 477 - (3)t
(1L)
399 . (6)t
(VI)
485
(2L)
(6L)
(III)
No. 76. F5 T (299)
(IX)
F6 . (2)t - 321 . 2 1 363
(lL
F7 . 1 1 364 - . 3 3 354 -
F6 . (M)t
F7 . (M)t
(I)
(I)
F6 . (2)t
F7.
No. 13. F5 T (165).*
452 . (2)t
327 . 2
(IV)
1
No. 10. F5 T (329).*
(IX)
- 218 . 2 1
- 234
417
(2 L)
290 407
* Tumour age. t All mice included, as no tumours appeared.
after thedevelopment ofbreast cancer. Accordingly it could bededuced that some
hybrid females possessed the agent before and after tumour development, which
may be the case, as the litters which were compared were late litters; further, some
females harboured the agent after tumour development and others showed an
increase in its amount, and still others showed the presence of the agent before
Average
tumour
age
(days).
Average
age of
mice
dying
without
tumours
(days).
Number
of mice
alive at
earliest
tumour
appear-
ance.
(Conse-
secutive
no. of
litter)
Number
of
t-tunours.
(X)
2
2
5
12
21
297
353
359
289
275
Average
tumour
age
(days).
330
286
334
289
281
Average
age of
mice
dying
without
tumours
(days).
454
506
327
372
(2L)
2
5
9
15
29
408
374
(2L)
298
(3L)
F4 . 1
F5 . 66
F6 . 7
F6 .
F7 .
2
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and a decrease or absence ofit after mammary tumour development. Andervont
and Dunn (1949) observed breast tumours in the progeny of a hybrid female
before tumour development and no tumours in mice ofthe litter secured after'the
female had developed cancer. The behaviour of mice in the progeny obtained
after the tumour appeared in their mother may greatly vary even in the case of
hybrid females ofthe same origin, probably as a result ofvariations in the genetic
make-up of individual females infiuencing the presence or transmission of the
agent.
In conolusion it may be stated that both the genetic constitution and hor-
monal stimulation play an important part in the development of mammary
cancer in the hybrid mice which were the subject of the present study, and that
the mammary tumour agent also appears to take a part in the origin of these
tumours.
Biological Testsfor the Presence ofthe Mammary Tumour Agent.
As soon as the first mammary tumours appeared in the hybrid mice, biological
tests for the presence of the agent were carried out. Altogether twenty-three
mammary tumours were tested and the results are shown in Table XIII. Ofthe
four mammary tumours which developed in (C57 x RIII)F1 hybrid females, two
showed the presence of the agent and two others failed to reveal the agent under
the conditions ofthe test. The age at which the two negative mammary tumours
developed was 10 and 17 months respectively. At first it appears surprising that
the tumour which developed at the age of 10 months failed to show the agent, as
the time ofstorage in desiccated state was equal to that ofanother breast tumour
which appeared in the same generation and which, although injected in smaller
quantity, induced tumours in the test mice but in distinctly smaller incidence
compared with that induced by other dried agent-harbouring tissues in previous
experiments (Dmochowski, 1945a, 1945b, 1946, 1948, 1949c). It must be stressed
that the method ofdesiccation ofthese two as well as ofall the other tumours was
thesame, andtheageofthetest miceusedwasin all cases approximatelythesame.
The only varying factors were the amount of tissue injected and the time of
storage. The longest period of storage in the ice-chest was that of a negative
tumour in a (C57 x RIII)F, hybrid female and amounted to 8 months. This
should not have made an appreciable difference in the test, as it was previously
shown that agent-harbouring tissue induced breast canoer in test mice after two
years of storage (Dmochowski, 1946). From the results of the tests of the four
tumours in the first generation of hybrid females it may be concluded that two
of them possessed the agent, and the two other negative tumours either did not
contain the agent or harboured only small quantities or a weak agent which could
not be shown under the conditions of the test. None of the tumours of the
progeny of (C57 x RIII)F1 No. 34 female whose tumour was found to harbour
the agent wastested, but ascanbe seen inFig. 2, fromthestudyofparent-offspring
correlation there was a definite tendency towards breast cancer development in
daughters of tumorous as well as non-tumorous mothers. From this as well as
from the high incidence of tumours it can be presumed that these tumours con-
tained the agent. The results of the tests ofbreast tumours which developed in
the progeny of the tumorous (C57 x RIII)F1 No. 69 female (Fig. 1), whose
tumour failed to reveal the agent, are ofinterest. Ofthe nine tumours tested in
the progeny of this female, six were found to harbour the agent and three failed
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to show the agent. Mammary tumours of (C57 x RIII)F2 No. 9 and No. 10,
daughters of No. 69 (C57 x RIII)F1 female, did not reveal the agent, although
they developed comparatively early at about 10 months. The (C57 X RIII)F2
No. 9 female had ten litters and her sister had seven litters. It may well be that
the considerable hormonal stimulation was responsible for the appearance of
breast cancer in these females, and more likely that the agent took part in the
development of these tumours but in quantities too small to be detected by the
test. (C57 x RIII)F3 No. 15 and No. 20, were the two females in the progeny
of (C57 x RIII)F2 No. 9 hybrid whose tumours were tested. The test showed
the presence of the agent in the tumour of No. 15 hybrid but not in that of No.
20 female, although the ages at which the two tumours developed were quite
comparable. It may well be that had the test a:nimals, in which the latter
tumour was tested, lived longer, the agent would probably have been detected.
In the fourth generation of the progeny of No. 69 (C57 x RIII)F1 hybrid, the
two breast tumours tested ofNo. 48 female, granddaughter ofNo.9 (C57 x RIII)F2
female, and of No. 50, daughter of No. 20 (C57 x RIII)F3 hybrid, were found to
harbour the agent. The first tumour developed at the age of 8 months after the
female had six litters, and the second at approximately 17 months after the
female had thirteen litters. It is of interest that both tumours showed the agent,
although the second developed comparatively late in life. In the fifth generation
of the same line three tumours were tested, those of No. 89 and 90 females, grand-
daughters of No. 15 (C57 x RIII)F3 agent-harbouring female and of No. 48
female, daughter of No. 50 (C57 x RIII)F4 agent-carrying hybrid. The agent
was detected in all three tumours. From the biological tests of mammary cancer
in the descendants ofthe original No. 69 (C57 x RIII)F1 tumorous hybrid female
in whose tumour the agent was not detected, it may be seen how necessaiy it is
to adopt a cautious attitude towards the results of biological tests. It appears
probable that the agent may have increased gradually in quantity in successive
generations of the descendants of this hybrid female, so that it eventually could
be detected by the method applied in the present biological tests. It is possible
that the treatment, such as desiccation, may have in part been responsible for the
negative results when tumours with small quantities of the agent were tested.
Had the mammary tumour of No. 69 (C57 x RIII)F1 hybrid only been tested
and the progeny of this female not raised, the conclusion would have been that
increased hormonal stimulation of a susceptible genetic substrate was responsible
for the appearance of this breast tumour. It may well be stated that hormonal
and genetic factors combined with the mammary tumour agent were responsible
for the development of the majority of the tested breast tumours in this line, and
probably also a weak or attenuated agent in the tumours negative in the biological
test.
In the progeny ofnon-tumorous (C57 x RIII)F1 No. 21 (Fig. 3), two tumours,
one of (C57 x RIII)F3 No. 69 and one of (C57 x RIII)F4 No. 93 hybrids were
tested. The agent was found in both tumours. Among the descendants of
tumour-free (C57 x RIII)F1 No. 38 hybrid (Fig. 5) two mammary tumours were
tested, one which developed in (C57 x RIII)F2 No. 33 female at the age of 17
months after she had eleven litters and one which arose in (C57 x RIII)F4 No.
39 hybrid at the age of 10-5 months after she had given birth to six litters. The
agent was detected in both mammary tumours. It is interesting to note the
difference in tumour incidence induced in the test mice by these two tumours.
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The first, which developed at the age of 17 months, gave only 14 per cent incidence
compared with 63 per cent incidence induced by the tumour which developed at
theage of 10*5 months. It appearsthatthesetwotumours differedintheamounts
oftheagent present. Amongthedescendants ofthenon-tumorous (C57 x RIII)Fj
No. 68hybrid (Fig. 4) four tumours were examined. The, tumour in No. 22 (C57 x
RIII)F2 female developed at the age of 10 months after she had nine litters, and
three breast tumours of No. 21, 47, and 49 (C57 x RIII)F3 hybrids, all of which
developed after the eighth litter at the age of 9, 12, and 10 months respectively.
All four tumours harboured the agent, yet, although they all arose comparatively
early in life, the incidence of tumours induced in the test mice by the tumour of
No. 22 F2 female was only 15 per cent compared with that of 30 to 67 per cent by
tumours ofthe third generation females, and that in spite ofthe time one ofthese
tumours (No. 49, F3) was stored, which was three times longer than that of No.
22 F2 tumour.
An attempt to correlate the appearance of tumours and the presence of the
agent with any particular coat colour of the hybrid mice showed that while all
F1 females were of " wild " colour, their progeny in general could be divided into
" wild ", " white " and " black " coat colours. Tumours developed in hybrid
mice of all three coat colours without particular connection with any coat colour.
Foulds (1949) recorded a similar observation in his C57 x RIII hybrids. Neither
the presence or absence of the agent, as shown in biological tests, was connected
with any particular coat colour.
Foulds (1949) detected the agent in the tumour of a (057 x RIII)F1 hybrid
which had been tested. Muhlbock (1952) failed to discover the agent in tumours
of five (C57 x d) hybrids which developed at ages varying from 20 to 30 months.
These hybrids came from earlylitters. Mammary tumours in hybrids from later
litters of C57 females were not tested, but the presence of the agent in these
tumours was assumed by Muhlbock (1952) on the basis ofa high tumour incidence
in the litters, although the average tumour age was 18 months. A search for the
agent in mammary tumours ofhybrid progeny from another (C) low-cancer-strain
but susceptible females and high-cancer-strain (03H) males led to the detection
ofthe agent in tumours which developed at an early age up to 12 months, although
on two occasions even such tumours were negative (Andervont, 1945b; Ander-
vont and Dunn, 1950b), while mammary tumours arising at a late age, in spite of
their high incidence, failed toreveal the agent (Andervont and Dunn, 1949, 1950b;
Andervont, 1950a). Yet, on one occasion a C strain female was found to harbour
the agent, although she developed breast cancer at the age of 21 months (Ander-
vont and Dunn, 1950b). Thus there may be exceptions in both early and late
developing tumours, as shown in the present study with dried tumour tissue and
in the experiments of Andervont and Dunn with fresh tumour tissues. Bio-
logical tests of some tumours appearing at a late age, as shown in the present
experiments, revealed the agent, although they failed in other. tumours of similar
late age. It is not known how far the recent observation of Andervont (1950b)
that small quantities of the agent may only be ascertained by observing at least
one or even two generations of the descendants ofthe inoculated test mice would
be helpful, but it is certainly worth trying in anyfuturetests ofmammary tumours
appearing at a late age. In some mammary cancers which developed up to the
age of 12 months, the agent could not be detected on several occasions in the
present study. Mammary tumour of No. 67 F1 female at the age of 10 months,
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two tumours ofNo. 9 and 10 F2 females at the age of 9 5 months and one tumour
of No. 20 F3 hybrid at the age of 8 months all failed to show the presence of the
agent. The last three females were descendants of No. 69 F1 hybrid, whose
tumour appeared at 17 months and failed to reveal the agent. All tumours
which developed in later generations of No. 69 F1 hybrid were found to possess
the agent. Andervont (1945b, 1950a) also failed to detect the agent in mice with
tumours at 8, 12, 14, 15 and 16 months. On the basis of the study of parent-
offspring correlation shown in pedigree charts, it appears probable that the nega-
tive tumours also harboured the agent possibly in quantities too small to be
detected by the tests applied.
In conclusion it may be stated that the results of the biological tests for the
presence of the agent in desiccated mammary tumours which developed in the
hybrid mice indicate a gradual accumulation offactors responsible for the appear-
ance of mammary cancer. It appears that there may be a certain threshold
below which it is difficult or not possible to show the agent in some mammary
tumours, at least by the methods so far employed, and only after combined
influence of inbreeding and intensive hormonal stimulation the presence of the
agent may become detectable. There is no reason to consider the biological
tests as inadequate, in view of the previously reported constant positive results
with dried agent-containing tissue, and also in view of the negative results occa-
sionally recorded by other workers with fresh material even from tumours which
developed early in life. Further, negative tests for the agent in dried tissue of an
86th transplant of a mammary tumour which originally harboured the agent
(Dmochowski, 1952) have been confirmed with fresh tissue of a 101st serial passage
of the same tumour. The negative findings may have been due either to small
quantities of the agent present in some tumours or to the kind of relationship
of the agent to other cell constituents in these tumours, such as close integration
with these constituents, different from that in other tumours which were found
positive in the biological tests.
Microscopical Appearance of Mammary Tumours.
In view of the availability of a large number of tumours of a comparatively
uniform origin a microscopical study of these tumours was made, and also an
attempt to correlate the morphological appearance of these tumours with the
presence or absence of the agent. Dunn (1945) and Andervont and Dunn (1950a)
pointed out the difficulties encountered in any classification of mammary tumours,
but having a large number of mammary tumours available they made an attempt
to classify these tumours into four main types: Type A-with acinar structure
predominating; Type B-showing a variable pattern, composed either of solid
groups of epithelial cells, or single layers of cuboidal cells having cystic spaces or
growing as capillary projections into cysts or cords of cells separated by an abun-
dant connective tissue; Type C-with many epithelial-Jined cysts, their epithe- lial lining invested by a layer of spindle cells; Type D-adeno-acanthoma, with
large areas composed
of
squamous elements (Andervont and Dunn, 1950b).
Types A and B corresponded with Type I and Types C and D corresponded with
Type II of a previous classification (Andervont and Dunn, 1948a). The latest
classification was adopted in the present study, as it served as a useful basis for
a comparison with the findings of the extensive studies of Andervont and Dunn
(1950b) on mice maintained in the United States.
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For comparison with the mammary tumours of C57 x RIII hybrids of the
present experiments, a group of 141 mammary tumours which developed in 128
RIII high-cancer-strain mice was available. Of these mice, seven had two
tumours and three had three tumours. Seventy-one tumours or 50-4 per cent
were of Type A and arose at an average age of 232 days (126 to 430 days); sixty-
eight or 48-2 per cent belonged to Type B and developed at an average age of
269 days (145 to 471 days); one tumour (0.7 per cent) was of Type D and was
observed at the age of 409 days; one tumour was a carcino-sarcoma and arose
at the age of 407 days. As can be seen the majority of tumours in this agent-
harbouring strain could be divided into roughly equal numbers of Type A and
Type B tumours.
The results of the study of 377 mammary tumours in 327 C57 x RIII hybrid
mice are shown in Table XIV. Among the 327 tumorous mice, 32 had two
tumours and 9 had three tumours. As shown in Table XIV, the majority of
tumours were of Type B. Most of the tumours (70.6 per cent) developed during
the first 12 months, and among them 53 were of Type A (19.7 per cent) and 215
(79.9 per cent) were Type B tumours; one unclassified mammary carcinoma also
belonged to this group of early tumours. After the first 12 months, 21 tumours
were of Type A (19.4 per cent), 77 tumours belonged to Type B (71.4 per cent),
9 tumours were of Type D (8-3 per cent), and 1 tumour was unclassified. An
analysis of the distribution of the different types of tumours in the progeny of
tumorous and non-tumorous (C57 x RII)F1 hybrids revealed that the progeny
ofboth types offemales had a number ofeach type oftumour similar to that found
in the total number of all tumours. Among the 120 mammary tumours of the
descendants of tumorous hybrid females, there were 19 (15.8 per cent) of Type
A, 99 (82.5 per cent) of Type B, and 2 (1.7 per cent) of Type D. Among the 225
tumours in the forcibly-bred progeny of non-tumorous hybrid females, 50 (22.2
per cent) belonged to Type A, 166 (73.8 per cent) to Type B, 7 (3.1 per cent) to
Type D, and 2 (0.9 per cent) were unclassified. There were 32 mammary tumours
examined in the progeny of a non-tumorous hybrid female which had been bred
in a normal way; five (15-6 per cent) were of Type A and 27 (84.4 per cent)
belonged to Type B. Among the multiple tumours, two or three types oftumours
were frequently encountered in the same female.. There was no difference in the
distributionoftypesoftumours in the progeny ofhybridswhich hadbeen subjected
to hormonal stimulation of varying intensity.
No correlation was observed between the type of tumour and its location or
size or rate of growth or litter sequence of the tumour-bearing mice or age of the
animal at which the tumour developed, except in the case of Type D tumours,
all of which developed in mice older than 12 months. Further, there was no
correlation between the types of tumours in litter mates or between tumours of
mothers and offspring.
Similar observations were reported by Andervont and Dunn (1950b) on (C x
C3H) susceptible hybrids, in which they found 38 per cent of Type A tumours,
44 per cent of Type B, 9 per cent of Type C, and 8 per cent of Type D. They
observed a correlation between the age at which mammary tumours appeared
and the type encountered, as in mice ofup to 19 months of age 63 per cent were
Type A tumours and 33 per cent Type B tumours, and in older mice 31 per cent
belonged to Type A and 48 per cent to Type B. In another study (Andervont,
1950a) 38 per cent of tumours were of Type A and 46 per cent Type B, and in
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mice older than 19 months 12 per cent of tumours were Type A and 63 per cent
Type B, thus showing a predominance of Type B at all ages. Andervont and
Dunn (1950b) found Type A tumour morefrequently in young micewiththe agent
and a greater variety oftypes in older mice apparently without the agent or with
a weak agent. They did not detect the agent in a C strain femalewith a squamous
type mammary tumour at a late age, yet in her progeny there appeared a Type A
tumour with the agent and one squamous type cancer without the agent. In
another two females ofthe samestrain, two tumours ofTypeA and B respectively
both harboured the agent; in their progeny all tumours with the agent were of
Type A. The majority of tumours in old mice were similar to those ofmice with
the agent (Andervont, 1945b, Andervont and Dunn, 1949). In hybrid mice
obtained from crossings ofagent-free low-cancer-strains the majority ofmammary
tumours were of Types C and D, and in those obtained from one of the parents
belonging to agent-free but high-cancer strain the majority of breast tumours
were ofTypes A and B (Andervont andDunn, 1948a). It appears that thegenetic
constitution of strains used for breeding hybrids influences at least the distribu-
tion of the various types of breast cancer.
There was no correlation in C57 x RIII hybrid females between the presence
of the agent, as shown in biological tests, and the type of tumour encountered.
Of the seventeen tumours in which the agent was found, ten were of Type B,
six of Type A, and one of Type D, and among the mammary tumours in which
the test failed to reveal the agent, four were Type B and two Type A, cancer
(Table XIII). The finding of the agent in Type D mammary tumour which
developed at 17 months is ofinterest, as it appears to indicate that not all squa-
mous type tumours which appear comparatively late need be agent-free tumours,
or possibly tumours in which for some as yet unknown reason it is difficult to
detect the agent. Two agent-harbouring tumours of (C57 x RIII)F1 hybrids
were of Type A (11 months) and Type B (16 months), and the two other
tumours in which the agent was not detected were also of Type A (10 months)
and Type B (11 months). Among the fifteen agent-harbouring tumours of
C57 x RIII hybrid progeny, five were Type A and arose at the age of 9 to 13
months, nine were Type B and developed at 7 to 17 months, and one Type D at
the age of 17 months. Two of Type A, two of Type B, and one Type D tumour
developed after the first 12 months. Among the tumours in the hybrid progeny
in which the agent was not detected, one was ofType A (18 months) and three of
Type B (8 to 10 months). In Andervont and Dunn's experience (1950b) the
majority of tumours (84 per cent) in hybrids developed at the age of 18 to 29
months and the rest during the first 17 months. They also found no correlation
between the microscopical appearance of a tumour and the presence ofthe agent.
Some of the early appearing tumours in which the agent could not be detected
were of Type A or B (Andervont, 1945b, 1950a). Foulds (1949) described the
microscopical appearance of breast tumours in his C57 x RIII hybrids as " un-
remarkable ". Miihlbock (1952) found the morphology of tumours in C57 x d
hybrids of little assistance in the study of the part played by the agent in the
development ofthese tumours. He also noted more unusual features in tumours
presumably free of the agent compared with those harbouring the agent, yet the
tumours accumulated in later litters of C57 mice following mating to high-cancer-
strain males, in which the agent was presumed to be present, had an appearance
like that of agent-harbouring breast tumours, in spite of their late average age
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ofdevelopment (20 months). There appears to be a greater variety in appearance
of mammary tumours in mice of strains in which the agent could not be detected
(Andervont and Dunn, 1950a; 1950b; Heston, Deringer, Dunn and Levillain,
1950; Muhlbock, 1952). In the present study all tumours of Type D developed
after 12 months of age. Similarly, Andervont and Dunn (1950b) found this type
of tumour to be very rare in younger hybrid mice in which the agent could be
detected, although, as shown in this study, this type of tumour even at a late
age may harbour the agent. Therefore the greater frequency of squamous
metaplasia in tumours of old hybrid mice, if the age of 17 months could be con-
sidered as a comparatively late age, need not indicate at least in every case their
development without participation of the agent, contrary to the previous sug-
gestion of Kirschbaum (1949). There is no doubt, however, about the greater
frequency of squamous type tumours in agent-free high-cancer-strain or suscep-
tible mice (Gardner, 1947; Heston, 1948; Heston, Deringer, Dunn and Levil-
lain, 1950) than in similar mice with the agent, but they do appear occasionally
in agent-carrying strains ofmiceas observed byDunn (1945), Andervont andDunn
(1950b), and in the present study.
From these observations it may be concluded that no particular microscopical
appearance ofmammary cancer in hybrid mice can be correlated with thepresence
or absence of the agent, in spite of the difference in distribution of the particular
types invarious strainsofmice. Thedistribution ofthevarioustypesofmammary
tumours appears to depend on their genetic constitution derived from the strains
used for obtaining the hybrid progeny. This genetic background probably also
influences the age at which the different types of tumours develop.
GENERAL DISCUSSION.
Andervont (1945a) was first to propose several explanations ofthe appearance
of mammary cancer in hybrid mice, presumably free of the agent. Gardner
(1947) observed that mammary tumours in mice deficient of the agent develop
late in life, grow slowly and are frequently of the squamous type. Since then a
considerable body ofdata has accumulated, which will be discussed in an attempt
to collate all the known observations on breast cancer in hybrid mice with the
findings ofthe present study in order to reveal the respective parts played by the
genetic, hormonal factors and the agent in the development ofmammary tumours
in these mice.
Genetic factors.
The influence ofthe genetic constitution on the development ofbreast tumours
in hybrid mice was revealed by the variations in the tumour incidence in hybrids
obtained from crossings of female and male mice of various low-cancer strains
differing in their susceptibility to tumour development in the presence of agent,
and also in hybrids from females ofthese strains mated to agent-carrying or agent-
free males of various high-cancer strains. Thus a variable but low tumour
incidencewas reported by Andervont and Dunn (1948a) in hybrids from reciprocal
crosses of low-cancer-strain (C, I, C57) mice and a higher but still comparatively
low tumour incidence in the hybrid progeny of low-cancer-strain (C) females and
agent-free high-cancer-strain (dba-) males, in spite of increased hormonal stimu-
lation. An even higher incidence of tumours developing at a late age (22 months
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or even later) was observed in hybrid progeny of susceptible low-cancer-strain
(C) females and high-cancer-strain (C3H) males with the agent (Andervont,
1945b; Andervont and Dunn, 1948b, 1949, 1950b). Hybrid progeny of another
susceptible agent-free strain (Ax) females and agent-carrying high-cancer-strain
(A) males developed no breast cancer, while the progeny of yet another agent-
free susceptible strain (C3Hb) females and high-cancer-strain (C3H) males with
the agent showed a high incidence of mammary rumours (Bittner, 1952a). Hybrid
females from low-cancer-strain female mice of low susceptibility to the agent
(C57 Black) and agent-harbouring high-cancer-strain (RIJI) males developed a
comparatively low (15 per cent) incidence of breast cancer, but at a comparatively
young (10 and 14 nonths) age (Foulds, 1947, 1949). A similar incidence of
tumours in hybrid mice of similar derivation has been observed by the writer,
but while in Foulds' experience the distribution of tumours suggested a strong
familial factor in their incidence, it was not discernible in the present study. The
tumorous and also the majority of non-tumorous hybrids gave rise to progeny
with tumours. Although the tumour incidence in the descendants of tumour-
free (C57 x RIII)F1 hybrids varied, it was comparatively high in the majority
of these mice. It appears that the hybrids and their progeny in the present
experiments showed both a strongtendency to tumour development and to the
transmission of the agent, and neither of the tendencies seemed to be limited to
certainC57 Black strain females, in spite of their low susceptibility to the agent
(Dmochowski, 1948). Andervont and Dunn (1948a) noted a parallelism between
the tendency to tumour development and susceptibility to the agent, as most
of the tumours which developed in hybrids from various crosses appeared in the
hybrid progeny ofsusceptible, even agent-free, male parents. While the tendency
to breast tumour development in the hybrids of Andervont and Dunn (1950b) was
not confined to some oftheir low-cancer-strain (C) mothers, the tendency to trans-
mission of the agent was limited to certain of these females.
The influence of genetic factors may not always lead to an increase in the
number of tumours, in spite of increased hormonal stimulation. Attempts to
increase the tumour incidence in the progeny of hybrids, obtained by back-
crossing to agent-carrying males or by brother to sister matings, and subjected
to forced breeding, resulted only in a decrease in the tumour incidence (Ander-
vont and Dunn, 1949). Contrary to these findings, in the present experiments,
brother to sister matings of descendants of non-tumorous hybrid mice, also
subjected to forced breedings, led to an increase in tumour incidence. It appears
that the main cause of the difference between these two sets of observations was in
the presence of the agent in the progeny of hybrids in the present experiments.
Genetic factors appear also to play a part in the development of breast cancer
in low-cancer-strain females following mating to high-cancer-strain males, even
in sublines of the same strain.While Andervont and Dunn (1950b) reported an
incidence of 8 per cent of tumours at a late age in their susceptible low-cancer-
strain (C) females, Bittner (1952a) observed a high incidence of 59 per cent at
18 months in the same strain females following mating to similar high-cancer-
strain(C3H) males. Susceptible females of another strain (Ax) were observed
by Bittner (1952a) to remain free of tumours after mating to agent-carrying
males of two high-cancer-strains (C3H and A), and of another susceptible strain
(C3Hb) to develop only a low incidence of breast cancer (3 per cent) when mated to
high-cancer-strain (C3H) males. Further the same strain (C) females which
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showed a high incidence after mating to one (C3H) high-cancer-strain male de-
veloped a muchlower incidence (30 per cent) when mated to other (A) high-cancer-
strain males. Females of strains with low susceptibility may show similar
differences. No tumours developed in C57 Black strain females after mating to
males of different agent-carrying strains, A and C3H strains (Bittner, 1952a),
RIII strain (Foulds, 1949) and in the present study, or d strain (Muhlbock, 1952).
In other low-cancer-strain (020 and dz) females an incidence of 8 to 23 per cent
was reported by Miihlbock (1952) as a result of mating to either high (d) or low-
cancer-strain (020) males. However, at least in some of the observations, diffe-
rences in the genetic constitution of the males must also be considered as well
as possible differences in the agent they harboured.
Thus the genetic constitution plays an important part in the development of
mammary tumours in hybrid mice derived from matings of various strains and
even in hybrids obtained from different sublines of the same strains.
Hormonal factors.
The influence of intensive hormonal stimulation may also vary in hybrids of
different derivations and in their progeny. Forcibly-bred (C57 x RIII)F1 hybrids
developed a 14 per cent incidence of tumours in the present study, while no
tumours appeared in theirlitter mates bred in a normal way. A similar incidence
of cancerwasalso noted by Foulds (1949) in forcibly-bred hybrids of similar origin.
Andervont (1950a) also reported an increased tumour incidence in hybrid progeny
of low-cancer-strain (C) females and agent-harbouring or agent-free high-cancer-
strain (C3H) males. In both types of hybrids those with seven or eight litters
showed a higher tumour incidence than those with three to five litters. The
importance ofhiormonal stimulation is particularly evident in the origin of breast
tumours in hybrid females from mice genetically predisposed to tumour develop-
ment but lacking the agent (Andervont, 1950a). This influence of hormonal
factors is not so evident in hybrids from strains with low susceptibility to the
agent (Andervont and Dunn, 1948a), and also may not always be so apparent in
hybrid progeny of agent-free high-cancer-strain males compared with that of
progeny from the same but agent-carrying males (Andervont and Dunn, 1949).
Although forcibly-bred progeny of both cancerous and non-cancerous hybrids in
the present study developed a high, but variable, incidence of tumours, this
incidence was not significantly different from that in the progeny of a normally-
bred hybrid, except for the age of appearance of breast cancer, possibly because
ofthe limited observation on progeny ofonly one female.
It isnot known how far the consecutive number oflitter from which the original
hybrids and their progeny originated may have been responsible for the difference
between the present observations on high breast-tumour incidence in the descen-
dants maintained by brother to sister matings and the decreasing tumour inci-
dence in similarly maintained progeny hybrids of different derivation (C x C3H)
reported by Andervont and Dunn (1949). The hybrids and their descendants
came from later litters than those in Andervont's and Dunn's experiments, which
originated from the first three litters. Hybrids of similar origin (Cx C3H) as
well as of other origin (C3Hb x C3H) and their progeny developed a low inci-
dence of breast tumours when derived from the first five litters, and a high inci-
dence, both virgin and breeding, if secured from seventh to tenth litter (Bittner,
1952a). Anincrease of breast tumours in hybrid progeny from later litters of
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C57 Black strain females mated to high-cancer-strain (d) males was also noted by
Muhlbock (1952). While on one hand these observations may be interpreted as
a result of the influence of hormonal factors, on the other hand they have been
interpreted (Bittner, 1952a; Muhlbock, 1952) as the result oI- a gradual increase
of the agent during its long latent period, or as an outcome of repeated matings
to agent-carrying males leading to the transmission of the agent to females.
Thus increased hormonal stimulation may be responsible for an increase in
tumour incidence in hybrids, especially those from agent-free male parents, but is
not always separable from that of the tumour agent or ofgenetic constitution.
The mammary tunmour agent.
-A consistently lower tumour incidence at higher tumour age was noted in
hybrids and their progeny born to males ofthe same but agent-free strain (Ander-
vont and Dunn, 1948a, 1949; Foulds, 1949; Andervont, 1950a; Bittner, 1952a).
The incidence varied from 25 to 100 per cent in hybrids from agent-carrying males
and between 9 and 50 per cent in those from agent-free males according to the
number of litters born to these hybrids (Andervont, 1950a), about 4 per cent of
the former hybrids developing tumours at an early age, and all of the latter
showing only tumours at a late age. It is not known, however, whether the
genetic constitution ofthe agent-free males was not sufficiently different from that
ofagent-carrying males of the same strain to influence the observed difference
in the mammary tumour incidence. Hybrid progeny from females of some (Ax)
strains mated to agent-harbouring high-cancer-strain (A) males remained free of
breast tumours (Bittner, 1952a), as well as that of females of other strains (C57)
mated to high-cancer-strain (A) males with the agent (Dmochowski, 1944b, 1945a).
Further, a high incidence oftumours was reported in the progeny ofsome hybrids
derived from matings of susceptible females (C3Hb x Ax) to agent-free high-
cancer-strain (C3Hb) males. The breast tumours of these hybrids may at least
in part have been produced by genetic and hormonal factors, in spite of the
apparent absence of the agent in the male parent. However, the presence of the
agent was assumed in these tumours, because of the high incidence of breast
cancer in the progeny of the tumorous hybrids (Bittner, 1952a). Foulds (1949),
Andervont (1950a) and Bittner (1950) interpreted the difference in tumour inci-
dence between hybrid progeny of agent-harbouring and agent-free high-cancer-
strain males as a result ofthe transfer ofthe agent by the male, especially in view
ofthe presence of the agent in various organs ofthe males (Andervont and Dunn,
1948a; Dmochowski, 1949c, Muhlbock, 1950b). This does not explain, however,
the appearance of tumours in the hybrid progeny of agent-free males and the
assumed appearance of the agent in these animals. Further, the difference in
the tumour incidence may not always be apparent. Miihlbock, (1952) noted in
hybrids from some low-cancer-strain (020, dz) females mated to high-cancer-
strain (d) males a similar tumour incidence to that in the hybrids from their
litter-mates mated to the same but agent-free (dz) males. These two types of
hybrids also induced a similar tumour incidence in susceptible test mice when used
as foster mothers. Thus the transfer of the agent by the male could not always
be demonstrated. Even after the 10th pregnancy of low-cancer-strain females
mated to males with and without the agent, these two types offemales when used
as foster mothers induced a similar tumour incidence in the test mice. The late
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tumour age (19 to 25 months) in both types of hybrids is characteristic and hor-
monal stimulation was assumed to be the cause of these tumours (Muhlbock,
1952). Thus the influence ofthe agent present in the male parent may not always
be evident, and probably the genetic constitution ofthe different strains may have
been responsible for the different results. Hormonal stimulation may have been
another factor responsible for the development of breast tumours in the hybrid
progeny of agent-free males. These explanations cannot be put forward for the
appearance of breast tumours in hybrids of some low-cancer-strain females mated
to high-cancer-strain males without the agent. In these tumours the agent was
assumed to be present because of the high incidence oftumoursin several succes-
sive generations of descendants of these hybrids. The presence of a latent agent
or small amounts of it in the "agent-free " males could be taken as another
possibility, and an increase ofthe agent orits activation by crossing oftwo different
genetic constitutions and by increased hormonal stimulation.
The development of mammary tumours in some low-cancer-strain females
(Andervont, 1945b; Andervont and Dunn, 1950b) and in many females of other
low-cancer-strains (Bittner, 1952a), the presence of the agent in tumours of these
females, in spite of their late (18 months) age of appearance (Bittner, 1952a),
further the appearance of breast cancer, or increased incidence of tumours in the
hybrid progeny of these females from late litters compared with none or low
incidence in the progeny ofearly litters (Bittner, 1952a) indicate the transmission
of the agent to low-cancer-strain females following repeated matings to high-
cancer-strain males harbouring the agent. This conclusion is further strengthened
by the failure to find a weak or attenuated agent in females of one susceptible
low-cancer-strain, in spite of repeated attempts. Foster nursing of susceptible
mice by these females (Andervont, 1945b); observation of several generations of
progeny of mice fostered by these females (Andervont and Dunn, 1948b);
exposure of young females to X radiation (Andervont and Dunn, 1950b)
oestrogenic stimulation of the females (Andervont, 1950a), all failed to
reveal the agent. Finally the possibility of an increase of the agent in
older females of this strain was not substantiated by the observation of similar
tumour incidence in hybrid progeny of both old and young females (Andervont
and Dunn, 1949). The development of mammary tumours in the descendants
ofboth tumorous and the majority ofnon-tumorous hybrid progenyofC57 females
which remained tumour-free after mating to agent-carrying males in the present
experiments as well as the detection of the agent in the majority of the tumours
tested indicate the transfer of the agent by RIII high-cancer-strain males. Al-
though not all (057 x RIII)F1 hybrids developed breast cancer, the transfer of
the agent must have taken place in the majority of the females. Similarly,
Bittner (1952a) noted a high incidence of tumours and the presence of the agent
in the descendants of cancerous and cancer-free hybrid progeny of certain strain
females mated to agent-carrying males. The presence of the agent was assumed
in mammary tumours which appeared in hybrid progeny of later litters of some
C57 females mated to high-cancer-strain (d) males (Muhlbock, 1952) because of
the high tumour incidence, in spite of the late age at which the tumours
appeared. The occasional transfer ofthe agent to the hybrid progeny in mother's
milk was therefore accepted by Muhlbock (1952). In some cases the agent was
detected in the tumours of hybrid progeny and their low-cancer-strain mothers,
in other cases all attempts failed to reveal it (Andervont and Dunn, 1948b, 1950b).
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Thus in low-cancer-strain females matedto agent-carrying males as well as in their
hybrid progeny a variable incidence of cancer was reported, with some tumours
revealing theagent in biologicaltests andsomenot; in othertumours thepresence
ofthe agent was assumed because ofhigh incidence ofbreast cancer in the descen-
dants of tumorous and/or non-tumorous hybrid females.
The transfer of the agent by high-cancer-strain males accepted as the most
likely source of the origin of the agent present in mammary tumours in hybrid
females, there remains the problem of the way in which the agent is transferred
to low-cancer-strain females. In view of the failure of Andervont and Dunn
(1949) to detect the agent in somelow-cancer-strain females after mating to agent-
possessing males, they suggested that the females either are not affected by the
agent or acquire it in insufficient amounts because of the transfer of the agent
in an attenuated form in utero. As a result of this transfer, only few tumours in
the hybrid progeny develop early and harbour the agent, while the majority of
tumours develop late without participation of the agent. Transfer of the agent
to embryos, however, appears to be doubtful, because ofthe absence ofthe agent
in high-cancer-strain embryos (Dmochowski, 1949c; Hummel and Little, 1949).
The passage of the agent from embryos, should they become infected in utero, is
also questionable because of the reported neutralisation of the agent by placenta
(Hummel, Little and Eddy, 1949). Transmission of the agent in utero would
also contradict the basis of the discovery of the agent itself. The increase in
tumour incidence in hybrid progeny of later litters (Andervont and Dunn, 1949;
Bittner, 1952a; Muhlbock, 1952) and the high incidence of tumours observed in
the descendants of later litters from hybrid females observed in the present
experiments may indicate either a transfer of the agent to females repeatedly
mated to agent-carrying males and/or gradual increase in the agent, transferred
by mating, during its long latent period under the influence ofhormonal stimula-
tion (repeated pregnancies). The low incidence of tumours observed in the
hybrid progeny of some derivations need not necessarily be interpreted in the
sameway asthe small number oftumours induced in mature mice which had been
given the agent, as suggested by Muhlbock (1952). A high incidence of tumours
obtained in mature mice of some strains after repeated injections of material
containing the agent (Dmochowski, 1945a; Muhlbock, 1952), and a small inci-
dence in mature mice of other strains (Bittner, 1952b), indicate that the genetic
constitution is the more likely explanation for the different tumour incidences in
hybrids of various derivations. Transmission of the agent by the sperm to low-
cancer-strain females, followed by its transmission to their hybrid progeny in the
mnilk ofthese females (Bittner, 1952a), appears to be the most likely way in which
the agent gains access to hybrid females, although in females of some strains it
may only occasionally take place (Miihlbock, 1952). The observation of several
generations ofdescendants ofhybrid females can give a clear picture whether the
transfer ofthe agent has taken place or not, as shown in the present study. Under
the same experimental conditions some hybrid females may develop mammary
tumours while their litter-mates may fail to show tumours; their descendants
may show a similar variation in their behaviour. Thus, the study of the beha-
viour ofthe hybrid progeny oflow-cancer-strain females, especially ofthe descen-
dants of later litters of the hybrid progeny, can only decide whether or not the
agent has been transferred by the male parent.
The observations on tumour development and the presence of the agent in
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the descendants of the hybrid progeny obtained by mating C57 Black straini
females to agent-carrying RIII strain males, made in the present experiments,
appear to indicate an interesting possibility in the agent-host relationship which
may be the outoome ofgradual mcrease in the amount of the agent or its activa-
tion in some hybrid females, while in other hybrid females it appears in quantities
large enough to be detected immediately with the development of breast cancer
in the first generation of hybrid progeny. This may be on one hand the result
of individual variations in the genetic constitution of hybrid females, and on the
other hand the outcome of varying quantities of the agent which the hybrid
females obtain from their low-cancer-strain mothers mated to high-cancer-strain
males. Within the framework of individual differences in the genetic make-up
and/or quantities of the agent obtained, inbreeding combined with hormonal
stimulation also exerts its influence. Thus we have the situation, encountered
in the present experiments, that under the same experimental conditions some
hybrid females develop mammary cancer and others (even their litter mates) do
not show breast cancer; some of the tumorous females do and others do not
reveal the agent; some of the progeny of the cancerous hybrid females may
develop mammary tumours which again may or may not reveal the agent, and
other progeny of the same cancerous females do not develop tumours; the pro-
geny of non-cancerous hybrid females may develop tumours which contain the
agent. The development ofbreast cancer in some ofthe (C57 x RIII)F1 hybrids
only after foroed breeding may be explained by the transmission of small quan-
tities of the agent by at least some of the C57 Black strain mothers after mating
to RIII agent-carrying males. The high, although varied, tumour incidence in
the progefny of these hybrids may be explained by the origin of these females as
well as of their progeny from late litters and therefore an increase or activation
of the agent in these litters, enhanced by inbreeding and increased hormonal
stimulation. Andervont and Dunn (1950b) also observed that under the same
conditions some low-cancer-strain females developed and others failed to develop
breast cancer, and some females with tumours possessed and others lacked the
agent. There was also no correlation between the presenco of the agent in these
females and its presence in their hybrid progeny, cancerous females with or with-
out the agent giving rise to hybrid progeny with only late tumours apparently
without the agent, or to progeny with both early tumours with the agent and late
tumours without the agent, although they were litter mates. Therefore, again,
the presence or absence of the tumour and/or the agent in the mother did not
necessarily involve the presence or absence of the agent in her progeny. Ander-
vont and Dunn (1950b) noted on several occasions among the hybrid progeny
with late tumours that their litter mates had early tumours with the agent, and
on one occasion a hybrid female with an early tumour harbouring the agent had
progeny with either no tumours or only late tumours without the agent, which
suggested the disappearance of the agent (Andervont and Dunn, 1949). Bittner
(1952a) also reported on the hybrid progeny of some derivations with low mam-
mary tumour incidence that some of them gave rise to descendants with a high
incidence of tumours harbouring the agent. Thus the variable results appear to
be due to variations in the genetic make-up ofboth the hybrid females and their
progeny, which in turn leads to variations in the amount ofthe agent transmitted.
A more favourable genetic make-up may account for an increased amount of the
agent and its detection. or the agent may be present in a constant amount and
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its detection is entirely dependent on the genetic constitution and hormonal
factors encountered in various individual hybrids.
Transmission of the agent by agent-carrying high-cancer-strain males is
further strengthened by the observation of Andervont, Shimkin, and Bryan
(1942), which disposes of the possibilty of a contagion of the hybrids or their
low cancer-strain mothers and also by the absence of the agent in excreta of
mice (Dmochowskiand Passey, 1950a, 1950b; Muhlbock, 1950a). This, ofcourse,
does not imply the transmission ofthe agent to all females, and even those which
had obtained the agent and developed tumours need not necessarily transmit it
to their progeny. It appears also that the paternal contribution, resulting in
different tumour incidences in hybrid progeny of the same low-cancer-strain
females and males of different high-cancer-strains, besides being genetic may also
be of non-genetic origin, because of the observed differences in the agent present
in these various high-cancer-strains (Dmochowski, 1945b; Bittner and Huseby,
1946). Thus, while (C57 x RIII)F1 hybrids develop -breast cancer under certain
conditions, no tumours appear in (C57 x A)F1 hybrid females treated in a similar
manner (Dmochowski, 1944b; 1945a). Similar observations weremadeby Bittner
(1952a) on hybrids of various other derivations. The appearance of mammary
tumours in some low-cancer-strain females (C3Hb x Ax) mated to agent-free
(C3Hb) males and the high incidence of tumours in their descendants, on the
basis of which the presence ofthe agent was assumed although the tumours were
not tested biologically (Bittner, 1952a), is one at the moment rather perplexing
observation. Sudden " de novo " appearance of the agent was therefore also
considered as a possible explanation ofsome ofthefindings (AndervontandDunn,
1949; Bittner, 1952a). This consideration was based on previous observations
of Bittner (1941) on the sudden appearance of the agent in some susceptible
(Ax) mice, deprived of the agent by foster nursing by low-cancer-strain mothers,
which remained free of the agent for seven generations, and on similar observa-
tions made recently by Bittner (1952a) on susceptible mice of another strain
(C3Hb) which remained free of the agent for sixteen generations following foster
nursing before the appearance of breast cancer in one of the females, which then
gave rise to progeny with a high incidence of mammary tumours. According to
the writer's opinion, these observations of a sudden appearance ofthe agent may
only show the length oftime during which the agent may lie dormant or the time
required before the agent, originally present in small amounts, increases in quan-
tity sufficient to induce breast cancer in combination with other known and un-
known factors. Ofthe known factors, either a change in the genetic constitution
of the animal concerned alone and/or increased hormonal stimulus may, at least
in part, be responsible for the activation of the agent.
Bittner (1939a) reported the appearance of some mammary tumours in mice
without the agent, and Strong (1943) stressed the influence of hormonal factors
in such tumours. The difficulties encountered in the detection of the agent in
breast tumours appearing late in the life of mice and the comparative ease with
which it could be shown in tumours developing early (Andervont, 1950a), further
the isolated tumours in hybrid progeny of early litters and the accumulation of
tumours in hybrid mice oflate litters (Miihlbock, 1952), led to the conclusion that
there may be two types of mammary tumours in mice. One type of tumour
would be the result of all three factors taking part in its development, the other
type would be the result of hormonal and genetic factors without participation
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of the agent (Andervont, 1950a; Muhlbock, 1952). However, the possibility
of the agent being involved in both types of tumours was not discounted by
Andervont (1950a). The genetic constitution and intensive hormonal stimulation
were considered adequate by Heston, Deringer, Dunn and Levillain (1950) to
give rise to mammary tumours in susceptible (C3Hb) mice, originally derived
from mice deprived of the agent by foster nursing, but they also stressed that
absolute proof of the absence of the agent from such tumours was lacking. The
appearance of only a fewtumours in the hybrid progeny from reciprocal matings
of these (C3Hb) mice with low-cancer-strain (C57) mice with no evidence of an
increase in tumour incidence in the hybrid progeny of later litters, as originally
reported by Bittner (1944) in mice ofagent-carrying strains or in hybrid progeny
from low-cancer-strain females and agent-carrying males, again led Heston and
Deringer (1952) to suggest that some mammary tumours develop in the absence
of the agent. Yet, in hybrid progeny of similar mice of other strains, Bittner
(1952a) observed the appearance of tumours harbouring the agent. Further,
the agent has been detected in some mammary tumours appearing in compara-
tively old hybrids, as shown by Bittner (1952a) and in thepresent study. In other
late tumours as well as occasionally also in early-developing breast cancers the
agent could not be detected by any, so far, employed testing procedures as noted
by Andervont (1950a), Andervont and Dunn (1950b), and by the writer.
Thus, intensive hormonal stimulation combined with a suitable genetic back-
ground influence the origin of mammary tumours in hybrid mice, increase their
incidence, and accelerate their appearance. There is no doubt that the mammary
tumour agent takes a part in the development of breast tumours appearing up
to a certain age, although not all tumours of early appearance in hybrid mice
reveal its presence. The conclusion that tumours in old hybrids do not harbour
the agent and are the result of a combined action ofhormonal and genetic factors
only should at least for the time being be suspended, in view of the discovery of
the agent in some mammary tumours appearing at an older age than 15 months
and the lack ofcorrelation between any microscopical appearance ofbreast cancer
and the presence or absence of the agent.
SUMMARY.
1. (C57 x RI11)F1 hybrid females, obtained by mating agent-free C57 Black
strain females to agent-harbouring RIII high-cancer-strain males, developed a
14 per cent incidence of mammary tumours at an average age of 13 months after
bearing in quick succession an average number of 6-4 litters. Their litter-mates,
bred in a normal way, died free of tumours after rearing an average number of
3 litters. None ofthe C57 strain mothers developed breast cancer, although they
lived to an average age of 19 months.
2. The descendants of tumour-free hybrid females which had been subjected
to forced breeding, maintained by brother to sister matings for several generations
and also forcibly bred, developed a lower incidence of tumours at a considerably
higher tumour age than similarly maintained progeny of hybrid females with
tumours. The difference between the progeny of these two types of hybrid
females gradually became smaller in successive generations of inbreeding. The
average tumour age in the normally bred progeny of one tumour-free hybrid
which had been bred in a normal way was considerably higher than that in the
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forcibly-bred progeny ofboth tumorous and tumour-free hybrids, and the tumour
incidence waslower than that in the descendants ofcancerous hybrids but approxi-
mated that in the progeny of non-cancerous hybrids.
3. A connection between inbreeding and hormonal stimulation and the de-
velopment of breast cancer in the descendants of the hybrids was revealed by an
increasing number of females which developed tumours after bearing five litters
in each successive generation ofthe progeny ofboth cancerous and non-cancerous
hybridfemales. Tnisand theincreasingnumberof micewith tumoursborn inthe
first litter may have also been the result ofan increase in the amount or activation
of the mammary tumour agent.
4. Analysis of parent-offspring correlation in the distribution of tumours in
the descendants of the hybrids revealed that the progeny of tumours and of the
majority of non-tumorous hybrids had a greater chance to develop cancer if the
parent developed cancer than if the parent died without a tumour. Thus there
was a strong indication of the presence of the agent in these hybrids and of its
transmission to their progeny, which showed an increasing number of tumours
following the combined influence of inbreeding and intensive hormonal stimula-
tion. The tendency to tumour development and transmission ofthe agent shown
by the hybrids was not limited to certain C57 strain female parents.
5. The number of tumours which arose in litters and their progeny obtained
before their hybrid mothers developed cancer and in those secured after tumour
appearance indicated that some hybrids appeared to harbour the agent before
and after tumour development, some only after, and others only before the
development of breast cancer. This may have been the result of variations in
the genetic make-up of individual hybrids and their influence on the presence
or transmission of the agent.
6. Biological tests for the presence of the agent in twenty-three mammary
tumours were positive in seventeen and negative in the remainder of tumours.
The age of tumours in which the agent was detected varied from 7 to 17 months,
and that oftumours in which theagent could not be detected from 8 to 18 months.
These tests, combined with the observed distribution of tumours in the descen-
dants of hybrid mice, showed that under the same experimental conditions some
hybrids developed tumours which either harboured the agent or failed to reveal
it, while other hybrids, even their litter mates, died without tumours. Some of
the progeny oftumorous hybrids failed to develop tumours and others ofthe same
females developed cancer in which again the agent was either demonstrated or
could not be shown. Some of the progeny of tumour-free hybrids developed
tumours which harboured the agent. As there was no reason to doubt the
adequacy of the tests, it is possible that the results were due to small quantities
of the agent or an attenuated agent present in some tumours or to its close inte-
gration with tumour cells, or to the agent present in a constant amount in animals
with a variable and low but gradually increasing susceptibility. There may be
a certain threshold below which it is difficult to detect the agent in some tumours,
and it becomes demonstrable in other tumours after inbreeding combined with
hormonal stimulation.
7. The study ofmicroscopical appearance of 377 mammary tumours in C57 x
RIII hybrid females and of 141 tumours in RIII strain mice showed no correlation
between the appearance of a tumour and its location, size, rate of growth, litter
sequence oftumour-bearing mice, or their age, except in squamous type tumours.
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which as a rule developed in older mice above the age of 12 months. There was
also no correlation between the appearance of mammary tumours in parents and
their offspring. No connection was found between the appearance of tumours
in hybrid mice and the presence or absence of the agent in these tumours. The
agent was also demonstrated in a tumour of the adeno-acanthoma type
which developed at an age of well over 12 months. The frequency of occurrence
of various types of mammary cancer and the age at which they develop appear
to be influenced by the genetic constitution ofhybrid mice.
8. The implications ofthese observations in correlation with thoserecorded on
hybrids of other derivations are discussed.
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